Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure
Phase
3Span
277 weeksSponsor
Juntendo UniversityIzunokuni, Shizuoka
Recruiting
1-1 of 1